
NHS privatisation was connected to over 500 deaths from treatable diseases in England over five years, a study from Oxford …
Sirana Pharma has announced a collaboration with Pfizer to investigate the potential identification and validation of a novel treatment concept …

Scientists have discovered that accelerated aging with HIV begins at the time of initial HIV infection. Researchers found that HIV …
OxSonics Therapeutics has announced the appointment of Dr Marianna Lalla as CMO. Marianna, a well-respected physician with significant experience in …
DFE Pharma has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. …

Metrion Biosciences has announced the appointment of Dr Benedetta Montagnini as Head of European Business Development. The appointment follows the …
Timeline On the 8 June, we had the pleasure of joining Veeva at their 2022 Life Sciences Summit in Zurich, …

The number of people waiting for routine hospital treatments has grown to 6.4 million, the highest since records began in …

New findings, published in Nature, show that a protein called GREM1 is key to regulating the type of cells found …

A class of viruses known to cause severe diarrheal diseases can grow in the salivary glands of mice and spread …

A start-up, called Priovant Therapeutics, has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for …

NICE has issued a positive Final Appraisal Document (FAD) which recommends tralokinumab, upadacitinib and abrocitinib for use within NHS England …
The NHS app will be updated over the next few years to include multiple new features, including remote video consultations …

Automata has announced a commercial collaboration with University Hospital Southampton (UHS) NHS Foundation Trust, to accelerate automation within laboratories, enhance …

Members of the British Medical Association (BMA) have voted to press ministers to agree to a pay rise of up …

Basilea Pharmaceutica has announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult …

The EMA has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in the active immunisation for the …

The CHMP of the EMA has adopted a positive opinion for the marketing authorisation of a bevacizumab biosimilar candidate, Vegzelma. …

Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme …

The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with fluorouracil and …